Outcomes in techniques of valve sparing aortic root replacement: A systematic review and meta‐analysis

医学 荟萃分析 主动脉根 主动脉瓣 主动脉瓣置换术 心脏病学 梅德林 内科学 外科 主动脉 狭窄 政治学 法学
作者
Steven Toh,Juliana Ang,Joel Jacob George,Ovin Jayawardena,Samiha Mahbub,Amer Harky
出处
期刊:Journal of Cardiac Surgery [Wiley]
卷期号:36 (1): 178-187 被引量:6
标识
DOI:10.1111/jocs.15132
摘要

OBJECTIVE To compare clinical outcomes of reimplantation versus remodeling in patients undergoing valve-sparing aortic root replacement (VSRR) surgery. METHOD Electronic database search at PubMed, Scopus, Embase, Ovid, and Google scholar was performed from inception to January 2020. Primary outcomes were aortic valve (AV) reintervention and postoperative grade of aortic insufficiency (AI) while secondary outcomes were 30-day mortality, reoperation for bleeding, and operative times. RESULTS A total of 21 articles met the inclusion criteria. A total of 1283 patients had reimplantation while 1150 had remodeling. No difference in preoperative demographics was noted except reimplantation patients were younger (48 ± 16 vs. 56 ± 15 years; p < .00001). The cardiopulmonary bypass and aortic cross-clamp times were shorter in the remodeling cohort (168 ± 38 vs. 150 ± 37 min; p = .0001 and 133 ± 31 vs. 112 ± 30 min; p = .0002, respectively). No difference in concomitant total arch surgery (14% in reimplantation vs. 15% in remodeling; p = .53). Postoperatively, there were similar stroke rates (3% in both cohorts; p = .54), rates of reoperation for bleeding (9% in reimplantation vs. 12% in remodeling; p = .88), and 30-day mortality (3% in reimplantation vs. 4% in remodeling; p = .96). No difference in early AV reintervention (1% in reimplantation vs. 2% in remodeling; p = .07), and late AV reintervention (4% in reimplantation vs. 7% in remodeling; p = .07). The AI of +2 grade was significantly lower in the reimplantation cohort (5% vs. 8%; p = .01). CONCLUSION Our study shows comparable clinical outcomes between both techniques. The practice of each technique is largely center and surgeon dependent. Larger sample size cohorts with minimal confounding factors are required to confirm the above findings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
会飞的猪发布了新的文献求助10
刚刚
刚刚
彭于晏应助逃亡的小狗采纳,获得10
1秒前
1秒前
1秒前
好货分享发布了新的文献求助10
1秒前
2秒前
zz6532发布了新的文献求助10
3秒前
无花果应助猪猪hero采纳,获得10
4秒前
DADing发布了新的文献求助20
5秒前
李大海完成签到,获得积分10
5秒前
野原白发布了新的文献求助10
6秒前
鹏鱼燕完成签到,获得积分10
6秒前
6秒前
xxvvxx发布了新的文献求助20
6秒前
cdercder应助momo采纳,获得10
7秒前
ccbb完成签到,获得积分10
7秒前
lcsw发布了新的文献求助10
8秒前
慕青应助安若采纳,获得10
8秒前
英俊的铭应助yue采纳,获得10
9秒前
10秒前
小鱼鱼Fish发布了新的文献求助60
10秒前
莳砜Sulfone完成签到 ,获得积分10
10秒前
11秒前
着急的千山完成签到 ,获得积分10
11秒前
11秒前
西瓜完成签到 ,获得积分10
11秒前
小小发布了新的文献求助10
11秒前
隐形曼青应助猪猪hero采纳,获得10
12秒前
王佳慧完成签到 ,获得积分10
13秒前
123发布了新的文献求助20
13秒前
believe完成签到,获得积分10
13秒前
13秒前
14秒前
14秒前
15秒前
mange完成签到 ,获得积分10
15秒前
Archer发布了新的文献求助10
15秒前
lp发布了新的文献求助10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6954393
求助须知:如何正确求助?哪些是违规求助? 8638202
关于积分的说明 18318382
捐赠科研通 6398810
什么是DOI,文献DOI怎么找? 3083290
关于科研通互助平台的介绍 2129366
邀请新用户注册赠送积分活动 2060037